Piperazine substituted indazole compounds as inhibitors of parg

MD4496795T2Active Publication Date: 2026-08-31IDEAYA BIOSCIENCES INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MDE20250106T
Authority / Receiving Office: MD · MD
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2023-03-22
Filing Date: 2023-03-22
Publication Date: 2026-08-31
Estimated Expiration: 2043-03-22

Application Information

Patent Timeline

22 Mar 2023

Priority

22 Mar 2023

Application

MDE20250106T

31 Aug 2026

Publication

MD4496795T2

IPC: C07D417/14; A61K31/433; A61P35/00

CPC: C07D417/14; A61P35/00; A61K31/496

Inventors: BARSANTI Paul A.; DILLON Michael Patrick

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to compounds of Formula (I): or a pharmaceutically acceptable salt thereof. The compounds of the invention are useful as inhibitors of poly ADP-ribose glycohydrolase (PARG). Additional utilities and advantages are described herein.

Need to check novelty before this filing date? Find Prior Art